Stretch and/or oxygen glucose deprivation (OGD) in an in vitro traumatic brain injury (TBI) model induces calcium alteration and inflammatory cascade

Frontiers in Cellular Neuroscience

Volumn 9, Issue AUGUST, 2015, Pages

  Salvador, Ellaine ^a   Burek, Malgorzata ^a   Förster, Carola Y ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Astrocytes; Blood brain barrier; Calcium level; Cell stretch; CEND; Oxygen glucose deprivation; Traumatic brain injury

Indexed keywords

CALCIUM ION; CLAUDIN 5; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OCCLUDIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; EXPERIMENTAL MODEL; INFLAMMATION; MEMBRANE PERMEABILITY; MOUSE; NONHUMAN; OXYGEN GLUCOSE DEPRIVATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

EID: 84940183365     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00323     Document Type: Article

References (65)

1. Ahn, M., Sherwood, E. R., Prough, D. S., Lin, C. Y., and DeWitt, D. S. (2004). The effects of traumatic brain injury on cerebral blood flow and brain tissue nitric oxide levels and cytokine expression. J. Neurotrauma 21, 1431-1442. doi: 10.1089/neu.2004.21.1431
2. Albert-Weissenberger, C., and Sirén, A. L. (2010). Experimental traumatic brain injury. Exp. Transl. Stroke Med. 2, 1-8. doi: 10.1186/2040-7378-2-16
3. Arend, W. (1991). Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. J. Clin. Invest. 88, 1445-1451. doi: 10.1172/JCI115453
4. Atlee, J. (2007). Complications in Anesthesia. Philadelphia, PA: Elsevier Health Sciences; Saunders Elsevier.
5. Audus, K. L., Bartel, R. L., Hidalgo, I. J., and Borchardt, R. T. (1990). The use of cultured epithelial and endothelial cells for drug transport and metabolism studies. Pharm. Res. 7, 435-451. doi: 10.1023/A:1015800312910
6. Audus, K. L., and Borchardt, R. T. (1991). "Transport of macromolecules across the capillary endothelium," in Targeted Drug Delivery, ed R. L. Juliano (New York, NY: Springer-Verlag), 43-70.
7. Bell, M., Kochanek, P., Doughty, L., Carcillo, J., Adelson, P., Clark, R., et al. (1997). Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J. Neurotrauma 7, 451-462. doi: 10.1089/neu.1997.14.451
8. Berrout, J., Jin, M., and O'Neil, R. G (2011). Critical role of TRPP2 and TRPC1 channels in stretch-induced injury of blood-brain barrier endothelial cells. Brain Res. 1436, 1-12. doi: 10.1016/j.brainres.2011.11.044
9. Blecharz, K. G., Burek, M., Bauersachs, J., Thum, T., Tsikas, D., Widder, J., et al. (2014). Inhibition of proteasome-mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro. Biol. Cell 106, 219-235. doi: 10.1111/boc.201300083
10. Bolaños, J., and Almeida, A. (1999). Roles of nitric oxide in brain hypoxia-ischemia. Biochim. Biophys. Acta 1411, 415-436. doi: 10.1016/s0005-2728(99)00030-4
11. Brockmann, K. (2009). The expanding phenotype of GLUT-1 deficiency syndrome. Brain Dev. 31, 545-552. doi: 10.1016/j.braindev.2009.02.008
12. Burek, M., Haghikia, A., Gold, R., Roewer, N., Chan, A., and Förster, C. Y. (2014). Differential cytokine release from brain microvascular endothelial cells treated with dexamethasone and multiple sclerosis patient sera. J. Steroids Hormonal Sci.5:128. doi: 10.4172/2157-7536.1000128
13. Burek, M., Salvador, E., and Förster, C. Y. (2012). Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model. J. Vis. Exp. 66:e4022. doi: 10.3791/4022
14. Cernak, I. (2005). Animal models of head trauma. NeuroRx 2, 410-422. doi: 10.1602/neurorx.2.3.410
15. Ceruti, S., Colombo, L., Magni, G., Viganò, F., Boccazzi, M., Deli, M. A., et al. (2011). Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier.Neurochem. Int. 59, 259-271. doi: 10.1016/j.neuint.2011.05.013
16. Cherian, L., Hlatky, R., and Robertson, C. S. (2004). Nitric oxide in traumatic brain injury. Brain Pathol. 14, 195-201. doi: 10.1111/j.1750-3639.2004.tb00053.x
17. 2+ and ischemic injury. N. Engl. J. Med. 314, 314.
18. 2+-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 10, 465-469. doi: 10.1016/0166-2236(88)90200-7
19. D'Atri, F., and Citi, S. (2002). Molecular complexity of vertebrate tight junctions (Review). Mol. Membr. Biol. 19, 103-112. doi: 10.1080/09687680210129236
20. Dinarello, C. (1991). Interleukin-1 and interleukin-1 antagonism. Blood 77, 1627-1652.
21. Dubrovskyi, O., Birukova, A. A., and Birukov, K. G. (2013). Measurement of local permeability at subcellular level in cell models of agonist- and ventilator-induced lung injury. Lab. Invest. 93, 254-263. doi: 10.1038/labinvest.2012.159
22. Ellis, E. F., McKinney, J. S., Willoughby, K. A., Liang, S., and Povlischock, J. T. (1995). A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes. J. Neurotrauma 12, 325-339. doi: 10.1089/neu.1995.12.325
23. Espinoza-Rojo, M., Iturralde-Rodríguez, K. I., Chanez-Cardenas, M. E., Ruiz-Tachiquin, M. E., and Aguilera, P. (2010). Glucose transporters regulation on ischemic brain: possible role as therapeutic target. Cent. Nerv. Sys. Agents Med. Chem. 10, 317-325. doi: 10.2174/187152410793429755
24. Faraci, F. M., Breese, K. R., and Heistad, D. D. (1994). Cerebral vasodilation during hypercapnia. Role of glibenclamide-sensitive potassium channels and nitric oxide. Stroke 25, 1679-1683. doi: 10.1161/01.STR.25.8.1679
25. Fineman, I. H. D., Smith, M., Yoshino, A., and Becker, D. P. (1993). Concussive brain injury is associated with a prolonged accumulation of calcium: a 45Ca autoradiographic study. Brain Res. 624, 94-102.
26. Förster, C. (2008). Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 130, 55-70. doi: 10.1007/s00418-008-0424-9
27. Förster, C., Silwedel, C., Golenhofen, N., Burek, M., Kietz, S., Mankertz, J., et al. (2005). Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J. Physiol. 565, 475-486. doi: 10.1113/jphysiol.2005.084038
28. Förstermann, U., Boissel, J. P., and Kleinert, H. (1998). Expressional control f the constitutive isoforms of nitric oxide synthase (NOS I and NOS III). FASEB 12, 773-790.
29. Gaetz, M. (2004). The neurophysiology of brain injury. Clin. Neurophysiol. 115, 4-18. doi: 10.1016/S1388-2457(03)00258-X
30. Gidday, J. M., Beetsch, J., and Park, T. S. (1999). Endogenous glutathione protects cerebral endothelial cells from traumatic injury. J. Neurotrauma 16, 28-36. doi: 10.1089/neu.1999.16.27
31. Gray, H. (2011). Current controversies in traumatic brain injury. Ann. Queenstown Update Anesth. 51-55.
32. Haslam, G., Wyatt, D., and Kitos, P. A. (2000). Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities. Cytotechnology 32, 63-75. doi: 10.1023/A:1008121125755
33. Hopkins, S., and Rothwell, N. J. (1995). Cytokines and the nervous system. I: expression and recognition. Trends Neurosci. 18, 83-88. doi: 10.1016/0166-2236(95)80029-2
34. Hovda, D. A., Becker, D. P., and Katayama, Y. (1992). Secondary injury and acidosis. J. Neurotrauma 9(Suppl. 1), S47-S60.
35. Jowers, C. T., Taberner, A. J., Dragunow, M., and Anderson, I. A. (2013). The cell injury device: a high-throughput platform for traumatic brain injury research. J. Neurosci. Methods 218, 1-8. doi: 10.1016/j.jneumeth.2013.04.020
36. Kader, A., Frazzini, V. I., Solomon, R. A., and Trifiletti, R. R. (1993). Nitric oxide production during focal cerebral ischemia in rats. Stroke 24, 1709-1716. doi: 10.1161/01.STR.24.11.1709
37. Kleinschnitz, C., Blecharz, K., Kahles, T., Schwarz, T., Kraft, P., Göbel, K., et al. (2011). Glucocorticoid insensitivity at the hypoxic blood-brain barrier can be reversed by inhibition of the proteasome. Stroke 42, 1081-1089. doi: 10.1161/STROKEAHA.110.592238
38. Kossmann, T., Hans, V., Imhof, H., Stocker, R., Grob, P., Trentz, O., et al. (1995). Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries. Shock 4, 311-317. doi: 10.1097/00024382-199511000-00001
39. Kumaria, A., and Tolias, C. M. (2008). In vitro models of neurotrauma. Br. J. Neurosurg. 22, 200-206. doi: 10.1080/02688690701772413
40. Lucas, S. M., Rothwell, N., and Gibson, R. (2006). The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, S232-S240. doi: 10.1038/sj.bjp.0706400
41. Maas, A., Stocchetti, N., and Bullock, R. (2008). Moderate and severe traumatic brain injury in adults. Lancet Neurol. 7, 728-741. doi: 10.1016/S1474-4422(08)70164-9
42. McKeon, R. J., Silver, J., and Large, T. H. (1997). Expression of full-length trkB receptors by reactive astrocytes after chronic CNS injury. Exp. Neurol. 148, 558-567. doi: 10.1006/exnr.1997.6698
43. Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., et al. (1994). Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients. Neurosci. Lett. 180, 147-150. doi: 10.1016/0304-3940(94)90508-8
44. Morales, D. M., Marklund, N., Lebold, D., Thompson, H. J., Pitkanen, A., Maxwell, W. L., et al. (2005). Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience 136, 971-989. doi: 10.1016/j.neuroscience.2005.08.030
45. Morrison, B. III. Elkin, B. S., Dollé, J. P., and Yarmush, M. L. (2011). In vitro models of traumatic brain injury. Annu. Rev. Biomed. Eng. 13, 91-126. doi: 10.1146/annurev-bioeng-071910-124706
46. Munaron, L., and Fiorio Pla, A. (2000). Calcium influx induced by activation of tyrosine kinase receptors in cultured bovine aortic endothelial cells. J. Cell. Physiol. 185, 454-463. doi: 10.1002/1097-4652(200012)185:3%3C454::AID-JCP17%3E3.0.CO;2-A
47. Neuhaus, W., Burek, M., Djuzenova, C. S., Thal, S., Koepsell, H., Roewer, N., et al. (2012). NMDA-receptor antagonist MK801 attenuates up-regulation of glucose uptake after oxygen/glucose deprivation in a blood-brain barrier in vitro model. Neurosci. Lett. 506, 44-49. doi: 10.1016/j.neulet.2011.10.045
48. Neuhaus, W., Gaiser, F., Mahringer, A., Franz, J., Riethmüller, C., and Förster, C. (2014). The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier. Front. Cell Neurosci. 8:352. doi: 10.3389/fncel.2014.00352
49. Reinhart, K., Bayer, O., Brunkhorst, F., and Meisner, M. (2002). Markers of endothelial damage in organ dysfunction and sepsis. Crit. Care Med. 30, S302-S312. doi: 10.1097/00003246-200205001-00021
50. Rothwell, N. J., and Hopkins, S. J. (1995). Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 18, 130-136. doi: 10.1016/0166-2236(95)93890-A
51. Rubin, L. L., and Staddon, J. M. (1999). The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22, 11-28. doi: 10.1146/annurev.neuro.22.1.11
52. Rzigalinski, B. A., Weber, J. T., Willoughby, K. A., and Ellis, E. F. (1998). Intracellular free calcium dynamics in stretch-injured astrocytes. J. Neurochem. 70, 2377-2385. doi: 10.1046/j.1471-4159.1998.70062377.x
53. 2+ on in vitro astrocyte injury. J. Neurochem. 68, 289-296. doi: 10.1046/j.1471-4159.1997.68010289.x
54. Salvador, E., Neuhaus, W., and Förster, C. (2013). Stretch in brain microvascular endothelial cells (cEND) as an in vitrotraumatic brain injury model of the blood brain barrier. J. Vis. Exp. 80:e50928. doi: 10.3791/50928
55. Shohamia, E., Ginisb, I., and Hallenbecka, J. M. (1999). Dual role of tumor necrosis factor alpha in brain injury Cytokine Growth Factor Rev. 10, 119-130.
56. Silwedel, C., and Förster, C. (2006). Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflamamtory stimuli. J. Neuroimmunol. 179, 37-45. doi: 10.1016/j.jneuroim.2006.06.019
57. Sims, J. E., and Smith, D. E. (2010). The IL-1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89-102. doi: 10.1038/nri2691
58. Thal, S., Schaible, E. V., Neuhaus, W., Scheffer, D., Brandstetter, M., Engelhard, K., et al. (2013). Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury. Crit. Care Med. 5, 1305-1315. doi: 10.1097/CCM.0b013e31827ca494
59. Touzani, O., Boutin, H., Chuquet, J., and Rothwell, N. (1999). Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J. Neuroimmunol. 100, 203-215. doi: 10.1016/S0165-5728(99)00202-7
60. Vandamme, W., Braet, K., Cabooter, L., and Leybaert, L. (2004). Tumour necrosis factor alpha inhibits purinergic calcium signalling in blood-brain barrier endothelial cells. J. Neurochem. 88, 411-421. doi: 10.1046/j.1471-4159.2003.02163.x
61. Weber, J., Rzigalinski, B. A., Willoughby, K. A., Moore, S. F., and Ellis, E. F. (1999). Alterations in calcium-mediated signal transduction after traumatic brain injury of cortical neurons. Cell Calcium 26, 289-299. doi: 10.1054/ceca.1999.0082
62. Wolterbeek, H., and van der Meer, A. J. (2005). Optimization, application, and interpretation of lactate dehydrogenase measurements in microwell determination of cell number and toxicity. Assay Drug Dev. Technol. 3, 675-682. doi: 10.1089/adt.2005.3.675
63. Xiuli, G., Meiyu, G., and Guanhua, D. (2005). Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem. Genet. 43, 175-187. doi: 10.1007/s10528-005-1510-5
64. Yu, A. S., Hirayama, B. A., Timbol, G., Liu, J., Basarah, E., Kepe, V., et al. (2010). Functional expression of SGLTs in rat brain.Am. J. Physiol. Cell Physiol. 299, C1277-C1284. doi: 10.1152/ajpcell.00296.2010
65. Yu, C. H., Yhee, J. Y., Kim, J. H., Im, K. S., Kim, N. H., Jung, D. I., et al. (2011). Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury. J. Vet. Sci. 12, 299-301. doi: 10.4142/jvs.2011.12.3.299